Contrarily, CD133 expression is not limited to intestinal stem or cancer-initiating cells; during the metastatic transition, CD133+ tumor cells may generate a more aggressive CD133- population, which can also initiate tumors in NOD/SCID mice [36]. Here, PROM1 is linked to cancer.